GW Pharmaceuticals and supplement retailer GNC have reportedly been among the companies meeting recently with a White House division to discuss aspects of CBD regulation.
The US Food and Drug Administration has announced a virtual public meeting to explore the potential sex (biological) and gender (psychosocial) differences in use and responses to cannabidiol (CBD) and other cannabinoids.
Rep. Kurt Schrader (D-OR) and Rep. Morgan Griffith (R-VA) have introduced the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 to allow hemp and hemp derived CBD to be legally marketed in dietary supplements.
Demetrix – one of a new wave of biotech firms producing cannabinoids via biosynthesis (rather than extracting them from cannabis plants) – has commenced 15,000-liter demo-scale fermentation production of CBG (cannabigerol), the first rare cannabinoid...
Hemp plants contain dozens of bioactive cannabinoid molecules and one of them, CBG, is starting to edge onto the main stage with its better known peer, CBD.
NatureBox – a VC-backed startup that burst onto the scene in 2012 as the Trader Joe’s of online snacking with curated subscription boxes – has evolved its business model over the years, making a move into bricks & mortar retail, and getting heavily...
The hemp/CBD industry may have gotten the cart before the horse in terms of extraction capacity and raw material supply, said an investment analyst familiar with the sector.
Canada-based Willow Biosciences Inc. has announced it will soon start to deliver its first samples of “ultra-pure, pharmaceutical grade” cannabigerol (CBG) from its 500-liter pilot production run.
A bill before the California State legislature would open the country’s largest market to dietary supplements and foods containing CBD, but advocates say time is running out while the machinery of state government is preoccupied with pandemic concerns.
